| Marty Wayne Cannon, PHARM D | |
|
1500 Hwy 25b, Heber Springs, AR 72543 | |
| (501) 362-2864 | |
| (501) 362-1984 |
| Full Name | Marty Wayne Cannon |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1500 Hwy 25b, Heber Springs, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356942072 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD08068 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marty Wayne Cannon, PHARM D 1500 Hwy 25b, Heber Springs, AR 72543 Ph: (501) 362-2864 | Marty Wayne Cannon, PHARM D 1500 Hwy 25b, Heber Springs, AR 72543 Ph: (501) 362-2864 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Celgene/Nippon Kayaku's Calsed earns Decision Resources' proprietary clinical gold standard status in 2013 for the treatment of extensive-disease small-cell lung cancer, following its approval for the indication in 2012.
Yesterday, Speaker Pelosi and the Democratic Leadership introduced a new version of the "Affordable Health Care for America Act" which provides federal funds for elective abortion, reauthorizes Indian Health Care without adding the Hyde Amendment, and mandates providing information about physician-assisted suicide in certain states.
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it has entered into a sponsored research agreement (SRA) with the University of Michigan to evaluate bone defect repairs using human stem cells. The one-year project, beginning in March, will be funded through the proceeds of a $108,746 grant from the National Institutes of Health (NIH) under the Small Business Innovative Research Program (SBIR).
Enzyme Indicators (EI's) have been proven as a revolutionary viable alternative to biological indicators (BI's) for Hydrogen Peroxide decontamination validation.
New research shows that a less-toxic combination of a targeted immune-based drug and a chemotherapy drug can produce long-term remissions in some chronic lymphocytic leukemia patients. And it does so without increasing the risk of later therapy-related myelodysplastic syndrome and acute myeloid leukemia, which can often occur with a three-drug combination used to treat these patients.
› Verified 1 days ago
Dr. Justin Davis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1500 Highway 25 B North, Heber Springs, AR 72543 Phone: 501-362-5837 | |
Rocky Martin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 W Main St, Heber Springs, AR 72543 Phone: 501-206-0146 Fax: 501-206-0215 | |
Dr. Chelsa Painter, PHARM.D., MBA Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 W Main St, Heber Springs, AR 72543 Phone: 501-206-0146 | |
William D. Bell, P.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 120 S 4th St, Heber Springs, AR 72543 Phone: 501-362-5853 Fax: 501-362-5854 | |
Dr. Joy Graves, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 W Main St, Heber Springs, AR 72543 Phone: 501-302-6010 Fax: 501-206-0335 | |
Samuel Blake Hutchins, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 408 W Main St, Heber Springs, AR 72543 Phone: 501-270-8888 Fax: 501-270-6677 |